Chinook Therapeutics, Inc. KDNY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

30/100

0/7 Pass

SharesGrow Intrinsic Value

There have been 50 recent insider transactions recorded for Chinook Therapeutics, Inc. (KDNY), including 5 buys and 42 sells. Total insider buying was valued at $37.21K and total insider selling at $9.19M.

Notable insiders with recent activity include Bjerkholt Eric, Dobmeier Eric, Griffin Michelle Renee. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — KDNY

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2023-08-11	Bjerkholt Eric	Chief Financial Officer	Return of Shares	8,400	-	-	-
2023-08-11	Dobmeier Eric	President, CEO	Return of Shares	11,300	-	-	-
2023-08-11	Griffin Michelle Renee	Director	Return of Shares	13,300	$13.88	$184.6K	-
2023-08-11	Akkaraju Srinivas	Director	Return of Shares	13,300	$13.88	$184.6K	-
2023-08-11	Greenman William Mariner	Director	Return of Shares	13,300	$13.88	$184.6K	-
2023-08-11	Azelby Robert	Director	Return of Shares	7,000	-	-	-
2023-08-11	Jerel Davis	Director	Return of Shares	13,300	$13.88	$184.6K	-
2023-08-11	Oxtoby Andrew	Chief Commercial Officer	Return of Shares	40,000	-	-	-
2023-08-11	Thomas Dolca	Director	Return of Shares	13,300	$13.88	$184.6K	-
2023-08-11	King Andrew James	Chief Scientific Officer	Return of Shares	8,400	-	-	-
2023-08-11	Frohlich Tom	Chief Operating Officer	Return of Shares	8,400	-	-	-
2023-08-11	Krishnan Mahesh	Director	Return of Shares	4,401	-	-	-
2023-08-01	King Andrew James	Chief Scientific Officer	Informative Sell	1,168	$39.03	$45.59K	19,157
2023-07-29	King Andrew James	Chief Scientific Officer	Option Exercise (Sell)	3,333	-	-	6,667
2023-05-30	Greenman William Mariner	Director	Informative Sell	1,155	$23.30	$26.91K	23,643
2023-05-26	Griffin Michelle Renee	Director	Option Exercise (Sell)	3,300	-	-	-
2023-05-26	Akkaraju Srinivas	Director	Option Exercise (Sell)	3,300	-	-	-
2023-05-26	Greenman William Mariner	Director	Option Exercise (Sell)	3,300	-	-	-
2023-05-26	Haghighat Ross	Director	Option Exercise (Sell)	3,300	-	-	-
2023-05-26	Jerel Davis	Director	Option Exercise (Sell)	3,300	-	-	-
2023-05-26	Thomas Dolca	Director	Option Exercise (Sell)	3,300	-	-	-
2023-04-24	Dobmeier Eric	President, CEO	Informative Buy	1,200	$22.26	$26.71K	301,138
2023-04-17	Jerel Davis	Director	Informative Sell	295,808	$20.75	$6.14M	443,713
2023-04-10	Azelby Robert	Director	Unknown	-	-	-	-
2023-04-10	Azelby Robert	Director	RSU Award	7,000	-	-	7,000
2023-04-04	Krishnan Mahesh	Director	Informative Sell	924	$23.01	$21.26K	1,275
2023-04-03	King Andrew James	Chief Scientific Officer	Informative Sell	5,000	$23.34	$116.72K	16,992
2023-04-01	Krishnan Mahesh	Director	Option Exercise	2,199	-	-	2,199
2023-03-01	Jerel Davis	Director	Informative Sell	36,751	$22.75	$836.09K	210,996
2023-02-28	Oxtoby Andrew	Chief Commercial Officer	RSU Award	40,000	-	-	40,000
2023-02-15	Oxtoby Andrew	Officer	Unknown	-	-	-	-
2023-02-10	Bjerkholt Eric	Chief Financial Officer	Option Exercise (Sell)	2,435	-	-	2,435
2023-02-10	Dobmeier Eric	President, CEO	Option Exercise (Sell)	20,248	-	-	20,248
2023-02-10	King Andrew James	Chief Scientific Officer	Option Exercise (Sell)	6,803	-	-	6,802
2023-02-10	Frohlich Tom	Chief Operating Officer	Option Exercise (Sell)	6,803	-	-	6,801
2023-01-31	Dobmeier Eric	President, CEO	Option Exercise (Sell)	24,999	-	-	50,001
2023-01-31	Bjerkholt Eric	Chief Financial Officer	Option Exercise (Sell)	7,333	-	-	14,667
2023-01-31	King Andrew James	Chief Scientific Officer	Informative Sell	3,244	$24.68	$80.07K	15,081
2023-01-31	Frohlich Tom	Chief Operating Officer	Option Exercise (Sell)	8,333	-	-	16,667
2023-01-30	Dobmeier Eric	President, CEO	Informative Sell	25,000	$24.54	$613.61K	271,676
2023-01-03	King Andrew James	Chief Scientific Officer	Informative Sell	10,000	$25.82	$258.18K	9,992
2022-12-22	Jerel Davis	Director	Other (Sell)	9,465	-	-	-
2022-12-14	Dobmeier Eric	President, CEO	Option Exercise	30,000	$0.35	$10.5K	271,676
2022-12-13	Frohlich Tom	Chief Operating Officer	Option Exercise (Sell)	10,000	-	-	43,847
2022-12-01	Bjerkholt Eric	Chief Financial Officer	Informative Sell	5,770	$22.29	$128.6K	32,847
2022-12-01	Dobmeier Eric	President, CEO	Gift (Given)	25,000	-	-	211,676
2022-11-30	Bjerkholt Eric	Chief Financial Officer	Option Exercise (Sell)	16,414	-	-	16,415
2022-11-07	Frohlich Tom	Chief Operating Officer	Option Exercise (Sell)	10,000	-	-	53,847
2022-10-06	Dobmeier Eric	President, CEO	Option Exercise (Sell)	30,796	-	-	30,797
2022-10-06	King Andrew James	Chief Scientific Officer	Option Exercise (Sell)	10,152	-	-	10,152

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry